Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.

Journal article

Rosenkranz M. et al, (2024), Life Sci Alliance, 7

Integrating vaccines and monoclonal antibodies into malaria prevention.

Journal article

Taylor TE. and Osier F., (2024), Nat Med

Malaria - Epidemiology, Treatment, and Prevention.

Journal article

Baden L. et al, (2023), N Engl J Med, 388

Asplenia and spleen hypofunction.

Journal article

Lenti MV. et al, (2022), Nat Rev Dis Primers, 8